News & Publications
Find our latest news and analysis here. From the daily Newsstand to the Quarterly Journal, we cover the full breadth of intellectual property law.
Written January 3, 2019
Senator Orrin Hatch (R-UT), Senator Thom Tillis (R-NC), and Representative Bill Flores (R-TX), on Tuesday, December 11 2018, introduced H.R. 7251, the “Hatch-Waxman Integrity Act of 2018.” The bill would require a generic manufacturer wishing to challenge a brand-name drug patent to choose between the Hatch-Waxman framework and inter partes review. The bill would apply similarly to patents on biologics. In addition, the bill stipulates that filing IPR patent challenges and profiting from resulting stock price changes is a form of prohibited market manipulation.
Broadcast Opportunities
Looking for opportunities to get published? Submit your work to the AIPLA Quarterly Journal or AIPLA Innovate Magazine.
Exhibitor and Sponsorship Opportunities
Highlight your brand at a premier intellectual property law event, webinar, podcast, or in one of our publications.
For rates, availability, or additional details, click here or contact:
Meghan Donohoe
COO
American Intellectual Property Law Association (AIPLA)
T| +1.703.415.1343
E| mdonohoe@aipla.org